Pharmacogenomics Fundamentals for Today's Clinicians - Online
Mayo Clinic and the Center for Individualized Medicine is working to close the gap between education and application of pharmacogenomics; made more prevalent by the increased access and affordability of genetic and pharmacogenomics test. This online content has been created to provide multidisciplinary education to those in a busy practice and not able to make it to one of the live CME courses offered.
Pharmacogenomics (PGx), the study of how one’s genes may affect an individual’s response to medication, is an emerging field within patient care. This course aims to prepare today’s clinician with the fundamentals of pharmacogenomics, including real-life case examples. Expert faculty provide the education needed to implement PGx into clinical practice.
Timothy B. Curry, M.D., Ph.D. - Course Director
|Garrett E. Schramm, Pharm.D., R.Ph. - Course Director|
Richard Weinshilboum, M.D.
Ann M. Moyer, M.D., Ph.D.
John D. Zeuli, Pharm.D., R.Ph.
This course is designed for Physicians, Physician Assistants, Nurse Practitioners, residents/fellow, Nurses, Pharmacists, Psychologists, Healthcare Executives.
- Explain foundational pharmacogenomics principles
- Describe the pharmacogenomics tests available for use and consideration in clinical practice
- Apply pharmacogenomics test results to make recommendations for an individualized medication management plan
Attendance at this Mayo Clinic course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Mayo Clinic College of Medicine and Science designates this educational activity for a maximum of 2.0 ACPE knowledge-based contact hours. Participants should claim only the credit commensurate with the extent of their participation in the activity.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.
- 2.00 ACPE
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Attendance
Course includes the following:
Pharmacogenomics from Bench to Bedside
Dr. Richard Weinshilboum, with over 40 years of research and clinical experience, sets the stage for this pharmacogenomics (PGx) course. He presents key, foundational principles, examples of early and current research, testing options and the trajectory of PGx in practice.
Pharmacogenomics (PGx) at the bedside is more than understanding drug-gene interactions. Dr. Zeuli explains foundational PGx concepts and how they apply to patient care.
Laboratory Aspects of Pharmacogenomics
Explore the laboratory side of pharmacogenomics testing using applications in patient care:
Pulling it all together, click through real-life cases and make decisions based on the key concepts learned earlier:
Cancellation and Refund Policy:
Request for cancellations must be submitted in writing to email@example.com. When cancelling a registration for a course 14 days or more before the course start date, a full refund (minus a $75 administrative fee) will be issued in the same form of payment the registration was received. No refunds are granted less than 14 days before the course start date.
Any use of this site constitutes your agreement to the Terms and Conditions of Online Registration.